Ocriplasmin injection is used to treat symptomatic vitreomacular adhesion. Symptomatic vitreomacular adhesion is an eye condition related to aging that may lead to blurring of vision or blindness.
Jetrea is a drug that belongs to a class of drugs that are known as proteolytic enzymes. It is used in the treatment of eye condition that is known as symptomatic vitreomacular adhesion or VMA. This condition is caused by jelly-like material that is known as vitreous gel in the eye sticking to the sensitive layer at the back of the eye. VMA is usually associated with aging.